Skip to main content
SpringerLink
Log in

Potential Target Antigens for Immunotherapy Identified by Serological Expression Cloning (SEREX)

  • Protocol
Target Discovery and Validation Reviews and Protocols

Part of the book series: Methods in Molecular Biology™ ((MIMB,volume 360))

Summary

Immunotherapy in cancer relies on the identification and characterization of potential target antigens that can be recognized by effector cells of the immune system. Several strategies have been developed to identify such antigens, which then can be used for immunization strategies. Serological analysis of recombinant tumor cDNA expression libraries (SEREX) identifies tumor antigens based on a spontaneous humoral immune response in cancer patients. SEREX is not limited to tumor types that can be grown in cell culture nor does it depend on T-cell clones that recognize the autologous tumor. SEREX-defined antigens need to be evaluated following an algorithm of several analytical steps before they become new target antigens for active immunotherapy: expression analysis to evaluate tumor association, serological analysis with sera from tumor patients and normal individuals to prove tumor-associated immunogenicity, identification of potential peptide epitopes for CD8 and CD4 T-cells, and evaluation in T-cell assays to demonstrate their potential use as vaccine targets. We recently identified a new breast cancer differentiation antigen designated as NY-BR-1 in an autologous breast cancer SEREX screening. The different steps of further evaluation are summarized in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Naito, Y., Saito, K., Shiiba, K., et al. (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res. 58, 3491–3494.

    CAS  PubMed  Google Scholar 

  2. Nakano, O., Sato, M., Naito, Y., et al. (2001) Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity. Cancer Res. 61, 5132–5136.

    CAS  PubMed  Google Scholar 

  3. Schumacher, K., Haensch, W., Roefzaad, C., and Schlag, P. M. (2001) Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res. 61, 3932–3936.

    CAS  PubMed  Google Scholar 

  4. Eerola, A. K., Soini, Y., and Paakko, P. (2000) A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. Clin. Cancer Res. 6, 1875–1881.

    CAS  PubMed  Google Scholar 

  5. van der Bruggen, P., Traversari, C., and Chomez, P. (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254, 1643–1647.

    Article  PubMed  Google Scholar 

  6. Boel, P., Wildmann, C., Sensi, M. L., et al. (1995) BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2, 167–175.

    Article  CAS  PubMed  Google Scholar 

  7. Van den Eynde, B., Peeters, O., De Backer, O., Gaugler, B., Lucas, S., and Boon, T. (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J. Exp. Med. 182, 689–698.

    Article  PubMed  Google Scholar 

  8. Boon, T. and van der Bruggen, P. (1996) Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183, 725–729.

    Article  CAS  PubMed  Google Scholar 

  9. Scanlan, M. J., Gure, A. O., Jungbluth, A. A., Old, L. J., and Chen, Y. T. (2002) Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188, 22–32.

    Article  CAS  PubMed  Google Scholar 

  10. Coulie, P. G., Brichard, V., Van Pel, A., et al. (1994) A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180, 35–42.

    Article  CAS  PubMed  Google Scholar 

  11. Brichard, V., Van Pel, A., Wolfel, T., et al. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178, 489–495.

    Article  CAS  PubMed  Google Scholar 

  12. Kawakami, Y., Eliyahu, S., Delgado, C. H., et al. (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc. Natl. Acad. Sci. USA 91, 6458–6462.

    Article  CAS  PubMed  Google Scholar 

  13. Wang, R. F., Robbins, P. F., Kawakami, Y., Kang, X. Q., and Rosenberg, S. A. (1995) Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes. [published erratum appears in J. Exp. Med. (1995) Mar 1;181(3),1261]. J. Exp. Med. 181, 799–804.

    Article  CAS  PubMed  Google Scholar 

  14. Wolfel, T., Hauer, M., Schneider, J., et al. (1995) A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 269, 1281–1284.

    Article  CAS  PubMed  Google Scholar 

  15. Gnjatic, S., Cai, Z., Viguier, M., Chouaib, S., Guillet, J. G., and Choppin, J. (1998) Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J. Immunol. 160, 328–333.

    CAS  PubMed  Google Scholar 

  16. Jochmus, I., Osen, W., Altmann, A., et al. (1997) Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide. J. Gen. Virol. 78(7), 1689–1695.

    CAS  PubMed  Google Scholar 

  17. Rammensee, H. G., Weinschenk, T., Gouttefangeas, C., and Stevanovic, S. (2002) Towards patient-specific tumor antigen selection for vaccination. Immunol. Rev. 188, 164–176.

    Article  CAS  PubMed  Google Scholar 

  18. Jager, E., Jager, D., and Knuth, A. (2002) Clinical cancer vaccine trials. Curr. Opin. Immunol. 14, 178–182.

    Article  CAS  PubMed  Google Scholar 

  19. Jager, E., Nagata, Y., Gnjatic, S., et al. (2000) Monitoring CD8 T cell responses to NY-ESO-1: correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA 97, 4760–4765.

    Article  CAS  PubMed  Google Scholar 

  20. Jaeger, E., Bernhard, H., Romero, P., et al. (1996) Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptides in vivo: implications for tumor vaccines with melanoma-associated antigens. Int. J. Cancer 66, 162–169.

    Article  CAS  PubMed  Google Scholar 

  21. Jager, E., Chen, Y. T., Drijfhout, J. W., et al. (1998) A simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J. Exp. Med. 187, 265–270.

    Article  CAS  PubMed  Google Scholar 

  22. Jager, E., Gnjatic, S., Nagata, Y., et al. (2000) Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA 97, 12,198–12,203.

    Article  CAS  PubMed  Google Scholar 

  23. Jager, E., Ringhoffer, M., Dienes, H. P., et al. (1996) Granulocyte-macrophagecolony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 67, 54–62.

    Article  CAS  PubMed  Google Scholar 

  24. Rosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., et al. (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat. Med. 4, 321–327.

    Article  CAS  PubMed  Google Scholar 

  25. Marchand, M., van Baren, N., Weynants, P., et al. (1999) Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int. J. Cancer 80, 219–230.

    Article  CAS  PubMed  Google Scholar 

  26. Sahin, U., Tureci, O., Schmitt, H., et al. (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92, 11,810–11,813.

    Article  CAS  PubMed  Google Scholar 

  27. Scanlan, M. J., Gout, I., Gordon, C.M., et al. (2001) Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immunity 1, 4.

    CAS  PubMed  Google Scholar 

  28. Ayyoub, M., Stevanovic, S., Sahin, U., et al. (2002) Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J. Immunol. 168, 1717–1722.

    CAS  PubMed  Google Scholar 

  29. Tureci, O., Chen,Y. T., Sahin, U., et al. (1998) Expression of SSX genes in human tumors. Int. J. Cancer 77, 19–23.

    Article  CAS  PubMed  Google Scholar 

  30. Chen,Y. T., Scanlan, M. J., Sahin, U., et al. (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94, 1914–1918.

    Article  CAS  PubMed  Google Scholar 

  31. Chen, Y. T., Gure, A. O., Tsang, S., et al. (1998) Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl. Acad. Sci. USA 95, 6919–6923.

    Article  CAS  PubMed  Google Scholar 

  32. Tureci, O., Sahin, U., Zwick, C., Koslowski, M., Seitz, G., and Pfreundschuh, M. (1998) Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc. Natl. Acad. Sci. USA 95, 5211–5216.

    Article  CAS  PubMed  Google Scholar 

  33. Eichmuller, S., Usener, D., Dummer, R., Stein, A., Thiel, D., and Schadendorf, D. (2001) Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc. Natl. Acad. Sci. USA 98, 629–634.

    Article  CAS  PubMed  Google Scholar 

  34. Ono, T., Kurashige, T., Harada, N., et al. (2001) Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA 98, 3282–3287.

    Article  CAS  PubMed  Google Scholar 

  35. Tureci, O., Sahin, U., Koslowski, M., et al. (2002) A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 21, 3879–3888.

    Article  CAS  PubMed  Google Scholar 

  36. Cho, B., Lim, Y., Lee, D. Y., et al. (2002) Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem. Biophys. Res. Commun. 292, 715–726.

    Article  CAS  PubMed  Google Scholar 

  37. Lee, S. Y., Obata, Y., Yoshida, M., et al. (2003) Immunomic analysis of human sarcoma. Proc. Natl. Acad. Sci. USA 100, 2651–2656.

    Article  CAS  PubMed  Google Scholar 

  38. Jager, D., Stockert, E., Jager, E., et al. (2000) Serological cloning of a melanocyte rab guanosine 5′-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res. 60, 3584–3591.

    CAS  PubMed  Google Scholar 

  39. Jager, D., Stockert, E., Gure, A. O., et al. (2001) Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res. 61, 2055–2061.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Onkologie, Nationales Centrum für Tumorerkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Germany

    Dirk Jäger

Authors
  1. Dirk Jäger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Immunology, Institute for Cancer Research, The Norwegian Radium Hospital, University of Oslo, Oslo, Norway

    Mouldy Sioud

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Humana Press Inc.

About this protocol

Cite this protocol

Jäger, D. (2007). Potential Target Antigens for Immunotherapy Identified by Serological Expression Cloning (SEREX). In: Sioud, M. (eds) Target Discovery and Validation Reviews and Protocols. Methods in Molecular Biology™, vol 360. Humana Press. https://doi.org/10.1385/1-59745-165-7:319

Download citation

  • DOI: https://doi.org/10.1385/1-59745-165-7:319

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-656-6

  • Online ISBN: 978-1-59745-165-9

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics

Search

Navigation